Statistics
Publications
35
Citations
10.4K
H-Index
25
Active since
2007
Şevin Turcan is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and molecular oncology.
Publications per year
2007–2023
35
35
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Şevin Turcan, Daniel Rohle, Anuj Goenka et al. · Nature · 2012 · 2K citations · Full text
Medicine, Cancer Biology, Oncology +14
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lü, Patrick S. Ward, Gurpreet S. Kapoor et al. · Nature · 2012 · 2K citations
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Varun Venkataramani, Dimitar Ivanov Tanev, Christopher Strahle et al. · Nature · 2019 · 1.2K citations · Full text
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle, Janeta Popovici-Müller, Nicolaos Palaskas et al. · Science · 2013 · 1.2K citations
Medicine, Cancer Biology, Oncology +17
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse, Stefan Pusch, Theresa Bunse et al. · Nature Medicine · 2018 · 537 citations
Life Sciences, Immunology, Oncology +12
1–5 of 35